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Most tissues in our bodies have
an astonishing ability to repair
themselves after injury, but a
notable exception is the adult
mammalian central nervous
system (CNS) — the brain and
spinal cord — which has little
innate capacity for repair. When
the axons of CNS neurons are
severed they are unable to
regenerate, accounting for the
devastating impairment induced
by spinal cord injury, stroke and
many other neurological
conditions. What accounts for
the failure of the CNS to
regenerate? One crucial factor is
that the adult CNS environment is
strongly inhibitory to
regenerating axons. In particular,
much recent attention has been
focused on the powerful
inhibition of degenerating myelin.
How does myelin inhibit the
growth of CNS axons? Three
different myelin proteins have
been identified that are strongly
inhibitory to most types of CNS
neurons: Nogo-A, myelin
associated glycoprotein (MAG)
and oligodendrocyte myelin
glycoprotein (OMgp) [1].
Remarkably, all three of these
myelin-associated inhibitor
factors  are able to bind to and
activate the same axonal multi-
protein receptor complex. The
proteins that generate this
receptor complex are the ligand
binding Nogo-66 receptor (NgR1)
and two signal transducing
binding partners, the p75
neurotrophin receptor (p75) and
the LRR and Ig domain-
containing, Nogo receptor-
interacting protein (LINGO-1)
[2,3]. Interaction of myelin-
associated inhibitors with the
p75/NgR1/LINGO-1 complex
activates the small GTPase
RhoA, which rigidifies the actin
cytoskeleton, thereby causing
growth cone collapse [4]. The
potential contribution of this
signaling pathway to CNS
regenerative failure is clearly
shown by the ability of RhoA
blockade to promote axon
regeneration in vivo after
injury [5,6].
Though the identification of the
p75/NgR1/LINGO-1 receptor
complex has been an exciting
advance, a perplexing mystery
has remained. Although NgR1
and LINGO-1 are widely
expressed throughout the CNS,
kinetochores. And if rings exist as
predicted, many questions remain
about the molecular details of how
these rings link to the Ndc80
complex at kinetochores to
regulate attachment of
microtubule plus ends and interact
with depolymerases and
stabilizers to sense tension and
control switching of microtubule
plus ends between polymerization
and depolymerization.
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Axon Regeneration: It’s Getting
Crowded at the Gates of TROY
A novel neuronal receptor complex that mediates myelin’s inhibitory
action on nerve fiber regeneration has at last been identified. This
discovery could be an important step towards promoting nerve
regeneration after stroke or spinal cord injury.
p75 is for the most part down-
regulated during development so
that it is not widely expressed in
the adult CNS. Many CNS neuron
types that are inhibited by myelin,
such as retinal ganglion cells, do
not express p75 in the adult CNS
[7]. Furthermore, although
neurons isolated from p75 mutant
mice are less inhibited by myelin
inhibitors in vitro, a significant
inhibitory activity remains [8], and
axon regeneration after spinal
cord injury is not enhanced in
these mice [9].
Might there be a p75
homologue that is more widely
expressed in the adult CNS that
could substitute for p75 in this
receptor complex? As p75 is a
member of the extensive TNF
receptor family, two research
groups [10,11] independently set
out to test this hypothesis. In
fact, several members of the TNF
receptor family have already
been reported to be widely
expressed in the CNS including
TROY, CD40, DR6, Fn14, TNFR1
and TNFR2. Using either ELISA or
cell binding assays, both groups
[10,11] found that, of these
proteins, only TROY could
interact with NgR1 and that its
interaction was nearly eight-fold
stronger than the interaction
between p75 and NgR1. And by
immunoprecipitation, both
groups demonstrated that TROY
is able to form a complex with
NgR1 and LINGO-1 [10,11].
So is TROY a functional
homolog of p75? To find out, both
groups [10,11] next tested
whether expression of the
TROY/NgR1/LINGO-1 complex in
non-neural cells can activate
RhoA in response to myelin-
associated inhibitor factor
binding. They found strong RhoA
activation, confirming that TROY
can substitute for p75 in the RhoA
signaling pathway. 
In elegant experiments, both
groups [10,11] also showed that
TROY regulates neurite outgrowth
of dorsal root ganglion neurons
and cerebellar granule neurons
grown on myelin, OMgp and
Nogo-66 in vitro. Increasing
neuronal TROY levels by
expression of full-length TROY
from a viral vector enhanced
myelin inhibitor-mediated
inhibition of neurite outgrowth,
whereas expression of a
truncated dominant negative
TROY (DN-TROY) significantly
lessened this inhibition.
Moreover, interfering with the
interaction between myelin-
associated inhibitors and the
TROY/NgR1/LINGO-1 complex by
addition of soluble TROY fusion
proteins to the culture media
greatly promoted neurite
outgrowth.
Taken together, these results
indicate that TROY transduces
myelin-mediated inhibition of
neurite outgrowth, provide
evidence that TROY can
functionally replace p75 in the
NgR1 complex, and add TROY to
the rapidly growing list of proteins
that mediate axon inhibition by
activating RhoA (Figure 1).
Is TROY responsible for the
residual inhibition of neurite
outgrowth in response to myelin
inhibitors observed in neurons
lacking p75 function in vitro? To
address this question, Park et al.
[10] very elegantly demonstrated
Dispatch 
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Figure 1. TROY is a novel NgR1 coreceptor and mediates CNS myelin mediated axon
outgrowth inhibition. 
The myelin associated inhibitor factors Nogo-66, MAG and OMgp block regeneration
of axons by binding to a shared receptor NgR1. In addition to an interaction between
NgR1, LINGO-1 and p75, a newly identified receptor complex consisting of NgR1,
LINGO-1 and TROY can transduce signaling upon binding of myelin associated
inhibitor factor to NgR1, leading to RhoA activation and axon outgrowth inhibition.
Blocking the formation of these receptor complexes by addition of dominant negative
(DN) forms of either p75 or TROY (DN-p75, DN-TROY) antagonizes the axon
outgrowth inhibitory effect of myelin associated inhibitor factor and myelin leading to
greatly improved neurite outgrowth of dorsal root ganglion and cerebellar granule
neurons in vitro.
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that dorsal root ganglion neurons
can be subdivided into p75-
expressing and non-expressing
neurons, which can be
distinguished by staining with
isolectin B4 (IB4). Dorsal root
ganglion neurons expressing IB4
do not express p75 and vice
versa. Both populations are
responsive to myelin-associated
inhibitors, indicating that p75 is
not essential for myelin-mediated
inhibition of neurite outgrowth.
But DN-TROY dramatically
enhances neurite outgrowth from
both IB4+ and IB4– dorsal root
ganglion neurons cultured on
myelin inhibitor substrates, and
IB4– neurons isolated from p75-
deficient mice still show a partial
response to myelin inhibitors [10].
Interestingly, however, even in
the absence of both TROY and
p75 function, neurite lengths
were still shorter than control,
suggesting the possibility that
additional, p75/TROY-
independent, signaling pathways
may yet exist that transduce
myelin-mediated inhibition of
neurite outgrowth. Nevertheless,
introduction of full length TROY
(FL-TROY) enhanced
responsiveness of p75-deficient
IB4– neurons, further
substantiating that TROY is a
functional homolog of p75 in
transducing the inhibitory signals
of myelin-associated
inhibitors [10]. 
To demonstrate conclusively
that TROY has a role in
transducing inhibition of neurite
outgrowth by myelin inhibitors,
Shao et al. [11] generated TROY-
deficient mice. These mice are
viable and exhibit no obvious
anomalies. As expected, dorsal
root ganglion neurons isolated
from TROY-deficient mice were
less sensitive to myelin-
associated neurite outgrowth
inhibitors, but they were only able
to completely overcome inhibition
at low concentrations of Nogo-66,
OMgp and myelin. Presumably
much of the residual neurite
outgrowth inhibition at higher
myelin inhibitor concentrations is
mediated by p75. From these
exciting new results it can be
concluded that TROY plays an
important role in mediating the
inhibitory effect of myelin
inhibitors via the
TROY/NgR1/LINGO-1 complex,
and can functionally replace p75.
What implications does the
discovery of this new receptor
complex have for promoting CNS
regeneration in vivo? The
functional redundancy of p75 and
TROY might very well explain the
lack of improved regeneration
after spinal cord injury in p75
knockout mice [9]. Thus, whether
TROY-deficient mice will display
enhanced regeneration is now a
very exciting question. As p75 is
widely upregulated after injury,
however, p75 might actually be
functionally redundant in TROY
knockout animals [12]. This issue
will no doubt soon be addressed
by the generation of TROY/p75
double-knockout mice. That
these mice will display enhanced
regeneration is far from certain,
as local administration of a p75
dominant-negative (DN-p75),
which also blocks TROY, does
not improve regeneration within
the injured spinal cord [9,10]. Not
only is it possible that additional
TNF-receptor family members are
involved, but also other NgR and
LINGO protein family members
(NgR2, NgR3, LINGO-2, LINGO-3
and LINGO-4) may play a role in
myelin induced axon outgrowth
inhibition [13–18]. Furthermore,
additional myelin inhibitory
proteins, such as Sema4D and
the amino-terminal domain of
Nogo-A, as well as unidentified
myelin-associated inhibitors and
their receptors, might mediate
axon outgrowth inhibition
independent of NgR1 receptor
complexes [19,20]. 
Despite all these unanswered
questions, the identification of
TROY is a major step forward in
understanding how myelin
inhibits axon regeneration,
providing new insight into the
signaling pathways involved in
regenerative failure and new
avenues for how repair may be
stimulated.
References
1. Schwab, M.E. (2004). Nogo and axon
regeneration. Curr. Opin. Neurobiol. 14,
118–124.
2. Yiu, G., and He, Z. (2003). Signaling
mechanisms of the myelin inhibitors of
axon regeneration. Curr. Opin. Neurobiol.
13, 545–551.
3. Mi, S., Lee, X., Shao, Z., Thill, G., Ji, B.,
Relton, J., Levesque, M., Allaire, N.,
Perrin, S., Sands, B., et al. (2004).
LINGO-1 is a component of the Nogo-66
receptor/p75 signaling complex. Nat.
Neurosci. 7, 221–228.
4. Yamashita, T., and Tohyama, M. (2003).
The p75 receptor acts as a displacement
factor that releases Rho from Rho-GDI.
Nat. Neurosci. 6, 461–467.
5. Fournier, A.E., Takizawa, B.T., and
Strittmatter, S.M. (2003). Rho kinase
inhibition enhances axonal regeneration
in the injured CNS. J. Neurosci. 23,
1416–1423.
6. Dergham, P., Ellezam, B., Essagian, C.,
Avedissian, H., Lubell, W.D., and
McKerracher, L. (2002). Rho signaling
pathway targeted to promote spinal cord
repair. J. Neurosci. 22, 6570–6577.
7. Chao, M.V. (2003). Neurotrophins and
their receptors: a convergence point for
many signalling pathways. Nat. Rev.
Neurosci. 4, 299–309.
8. Wang, K.C., Kim, J.A., Sivasankaran, R.,
Segal, R., and He, Z. (2002). P75
interacts with the Nogo receptor as a co-
receptor for Nogo, MAG and OMgp.
Nature 420, 74–78.
9. Song, X.Y., Zhong, J.H., Wang, X., and
Zhou, X.F. (2004). Suppression of
p75NTR does not promote regeneration
of injured spinal cord in mice. J.
Neurosci. 24, 542–546.
10. Park, J.B., Yiu, G., Kaneko, S., Wang, J.,
Chang, J., and He, Z. (2005). A TNF
receptor family member, TROY, is a
coreceptor with Nogo receptor in
mediating the inhibitory activity of myelin
inhibitors. Neuron 45, 345–351.
11. Shao, Z., Browning, J.L., Lee, X., Scott,
M.L., Shulga-Morskaya, S., Allaire, N.,
Thill, G., Levesque, M., Sah, D., McCoy,
J.M., et al. (2005). TAJ/TROY, an orphan
TNF receptor family member, binds
Nogo-66 receptor 1 and regulates axonal
regeneration. Neuron 45, 353–359.
12. Dubreuil, C.I., Winton, M.J., and
McKerracher, L. (2003). Rho activation
patterns after spinal cord injury and the
role of activated Rho in apoptosis in the
central nervous system. J. Cell Biol. 162,
233–243.
13. Neumann, H., Schweigreiter, R.,
Yamashita, T., Rosenkranz, K., Wekerle,
H., and Barde, Y.A. (2002). Tumor
necrosis factor inhibits neurite outgrowth
and branching of hippocampal neurons
by a rho-dependent mechanism. J.
Neurosci. 22, 854–862.
14. Demjen, D., Klussmann, S., Kleber, S.,
Zuliani, C., Stieltjes, B., Metzger, C., Hirt,
U.A., Walczak, H., Falk, W., Essig, M., et
al. (2004). Neutralization of CD95 ligand
promotes regeneration and functional
recovery after spinal cord injury. Nat.
Med. 10, 389–395.
15. Venkatesh, K., Chivatakarn, O., Lee, H.,
Joshi, P.S., Kantor, D.B., Newman, B.A.,
Mage, R., Rader, C., and Giger, R.J.
(2005). The Nogo-66 receptor homolog
NgR2 is a sialic acid-dependent receptor
selective for myelin-associated
glycoprotein. J. Neurosci. 25, 808–822.
16. Fischer, D., He, Z., and Benowitz, L.I.
(2004). Counteracting the Nogo receptor
enhances optic nerve regeneration if
retinal ganglion cells are in an active
growth state. J. Neurosci. 24, 1646–1651.
17. Zheng, B., Atwal, J., Ho, C., Case, L., He,
X.L., Garcia, K.C., Steward, O., and
Tessier-Lavigne, M. (2005). Genetic
deletion of the Nogo receptor does not
reduce neurite inhibition in vitro or
promote corticospinal tract regeneration
in vivo. Proc. Natl. Acad. Sci. USA 102,
1205–1210.
18. Kim, J.E., Liu, B.P., Park, J.H., and
Strittmatter, S.M. (2004). Nogo-66
Current Biology Vol 15 No 8
R304
Buzz Baum and Patricia Kunda
Actin filaments help control the
dynamic shape of all eukaryotic
cells [1]. They grow in a polarised
fashion via the addition of
ATP–actin monomers to the
filament ‘barbed end’. As a
filament ages, ATP is rapidly
hydrolysed and phosphate
released. Filamentous ADP–actin
is then disassembled by the
removal of subunits from the
polymer’s slow growing or
‘pointed end’, and the ADP
moiety is exchanged for ATP to
ready actin monomers for
another round of polymerisation.
In a eukaryotic cell, this cycle of
actin filament growth and
disassembly is regulated at each
step by a diverse set of actin-
binding proteins. As the rate-
limiting step in the formation of
an actin filament from purified
actin–ATP monomers is the
generation of dimeric and
trimeric actin nuclei, actin
filament nucleation is likely to be
a key point of control in this
process [1]. It is only recently,
however, that the Arp2/3
complex and formins have been
identified as distinct factors that
can catalyze de novo actin
filament formation. Now, Quinlan
et al. [2] have identified Spire as
a third class of actin nucleator.
The highly conserved, multi-
subunit Arp2/3 complex was the
first actin nucleation factor to be
characterized [3]. When activated,
its two actin-like subunits, Arp2
and Arp3, serve as a template for
monomer addition by mimicking
the ‘barbed end’ of a growing
actin filament [4]. The Arp2/3
complex also interacts with the
sides of existing actin filaments:
this augments its nucleation
activity, so that the Arp2/3
complex generates new actin
filament branches at a
characteristic angle of 70 degrees
to the host filament. As a result of
these simple biochemical
properties, Arp2/3-dependent
actin filament formation is auto-
catalytic and generates an
expanding, branched network of
filaments similar to that seen in
the lamellipodia of many motile
cells [1].
The formins catalyze de novo
actin filament formation via a
completely different mechanism
[5]. Formins dimerize to form a
hoop-shaped structure that acts
like a ‘barbed end’ filament cap
to stabilize the formation of an
adjacent actin dimer.
Remarkably, this nascent, formin-
bound actin seed is able to
elongate by the insertion of
ATP–actin monomers between
the formin cap and the ‘barbed
end’ of the filament. 
Although it remains to be
established exactly how this is
achieved, an attractive model is
that one subunit of the formin
dimer binds an actin subunit at
the tip of the filament ‘barbed
end’, while the other subunit of
the dimer catalyses addition of an
ATP–actin monomer to the
opposite strand of the actin
filament [5,6]. As the filament
elongates, the formin dimer will
then step between staggered
actin subunits at the filament tip
as if climbing a growing spiral
staircase. The ‘leaky’ dimeric
formin cap also protects the
growing filament from other
‘barbed end’ capping proteins. As
a result, formin-induced actin
nucleation generates long,
unbranched bundles of actin
filaments, like those used to
construct actin rings during
cytokinesis.
With the actin field still buzzing
over the discovery of formin-
dependent nucleation, Quinlan et
al. [2] have identified a further
novel mechanism of actin
filament nucleation that is
catalyzed by Spire.
The Spire gene was first
identified, together with
Cappuccino, in a Drosophila
screen for mutations affecting
oocyte polarity [7]. Although it is
not clear how the oogenesis
defects arise in the two mutants,
aspects of this phenotype can be
mirrored by loss of the actin-
nucleotide exchange factor
profilin, or by feeding flies with
the actin poison cytochalasin D,
implying that the phenotype
reflects an underlying reduction in
the rate of actin filament
formation [8]. This inference was
confirmed when the
corresponding genes were cloned
and Cappuccino was found to
encode a formin [8], and Spire a
conserved metazoan protein that
has multiple copies of a well-
characterised actin-binding
domain, the WH2 motif [9].
WH2-like motifs are present in
a wide range of actin binding
receptor prevents raphespinal and
rubrospinal axon regeneration and limits
functional recovery from spinal cord
injury. Neuron 44, 439–451.
19. Moreau-Fauvarque, C., Kumanogoh, A.,
Camand, E., Jaillard, C., Barbin, G.,
Boquet, I., Love, C., Jones, E.Y.,
Kikutani, H., Lubetzki, C., et al. (2003).
The transmembrane semaphorin
Sema4D/CD100, an inhibitor of axonal
growth, is expressed on
oligodendrocytes and upregulated after
CNS lesion. J. Neurosci. 23, 9229–9239.
20. Schweigreiter, R., Walmsley, A.R.,
Niederost, B., Zimmermann, D.R., Oertle,
T., Casademunt, E., Frentzel, S.,
Dechant, G., Mir, A., and Bandtlow, C.E.
(2004). Versican V2 and the central
inhibitory domain of Nogo-A inhibit
neurite growth via p75NTR/NgR-
independent pathways that converge at
RhoA. Mol. Cell. Neurosci. 27, 163–174.
Stanford University School of Medicine,
Neurobiology Department, Sherman
Fairchild Science Building, Room D129,
299 Campus Drive, Stanford, California
94305-5125, USA.
E-mail: mandemak@stanford.edu
DOI: 10.1016/j.cub.2005.04.002
Dispatch 
R305
Actin Nucleation: Spire — Actin
Nucleator in a Class of Its Own
The rate limiting step for actin filament polymerisation is nucleation,
and two types of nucleator have been described: the Arp2/3 complex
and the formins. A recent study has now identified in Spire a third class
of actin nucleator. The four short WH2 repeats within Spire bind four
consecutive actin monomers to form a novel single strand nucleus for
‘barbed end’ actin filament elongation.
